Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.